RES-Q+ is an EU Horizon-funded research initiative aimed at revolutionising stroke care by integrating existing stroke data with digital technology and artificial intelligence (AI). The project seeks to make stroke treatment faster, more effective and widely accessible. Building on the foundation of the Registry of Stroke Care Quality (RES-Q), an established system that helps hospitals track and enhance stroke care quality, RES-Q+ takes stroke management to the next level.
About the RES-Q registry
RES-Q is a global stroke care database that collects information on stroke treatment. With data from over 92 countries and more than 2,100 hospitals, it has become one of the world’s largest stroke registries. To date, RES-Q has recorded information from over 580,000 patients, providing essential insights into stroke care trends, treatment gaps and opportunities for improvement.
Why RES-Q+ matters
In stroke care, every minute counts – timely, high-quality treatment can save lives and improve recovery. The aim of RES-Q+ is to enhance stroke care by ensuring quality treatment throughout the entire patient journey – as the current RES-Q work only collects information related to when someone is in hospital.
The project, which involves stroke survivors and clinicians, started in 2022 and by the close of the project in 2026 it will bring:
- Automated data collection
RES-Q+ automates registry input by importing hospital discharge letters, so doctors and nurses do not have to enter data manually. This reduces mistakes and saves valuable time.
- AI virtual assistant tools to improve provision of stroke care
Virtual assistant tools will support medical teams to check how well their care processes are working and find ways to improve care, leading to better care and recovery for patients.
- AI virtual assistant tools to enhance follow-up care and rehabilitation
Virtual assistant tools are being developed in collaboration with stroke survivors to track their recovery after they leave hospital. This will ensure they get the right follow-up care and referrals to support their long-term recovery
Hendrik Knoche, project co-leader at Aalborg University, says:
“We are excited by the progress of our project so far. By involving both patients and clinicians in developing the Virtual Assistants, we ensure the technology truly meets their needs.”
Arlene Wilkie, Director General of the Stroke Alliance for Europe, highlights the impact on stroke survivors:
“By co-developing Virtual Assistants with stroke survivors, we can improve follow-up care and make treatment more personalised and accessible – with the potential to transform the lives of millions across Europe.”
For more information about the project
Or click to visit the RES-Q+ website
Or contact SAFE on research@safestroke.eu
RES-Q+ has received funding from the European Union under grant agreement No 101057603. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them
*RES-Q+ partners
- Institute of Health Information and Statistics of the Czech Republic
- Aalborg University, Denmark
- Charles University, Czechia
- Technical University Dublin, Ireland
- ALANA, Ireland
- Trinity College Dublin
- Ontotext, Bulgaria
- University of Murcia, Spain
- Timelex, Belgium
- Chino.io, Italy
- Masaryk University, Czechia
- Vall d’Hebron Institute of Research, Spain
- Boehringer Ingelheim, Germany
- World Stroke Organisation, Switzerland
- Stroke Alliance for Europe, Belgium
- National and Kapodistrian University of Athens, Greece
- Institute of Psychiatry and Neurology, Poland
- University Hospital of Bucharest, Romania
- Multiprofile Hospital for Active Treatment in Neurology and Psychiatry, Bulgaria
- Health Management Institute, Czechia
- University of Glasgow, United Kingdom
- International Clinical Research Center at St. Anne’s University Hospital Brno, Czechia
